BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 14568947)

  • 1. M cell DNA vaccination for CTL immunity to HIV.
    Wang X; Hone DM; Haddad A; Shata MT; Pascual DW
    J Immunol; 2003 Nov; 171(9):4717-25. PubMed ID: 14568947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein.
    Kaneko H; Bednarek I; Wierzbicki A; Kiszka I; Dmochowski M; Wasik TJ; Kaneko Y; Kozbor D
    Virology; 2000 Feb; 267(1):8-16. PubMed ID: 10648178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity.
    Belyakov IM; Moss B; Strober W; Berzofsky JA
    Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4512-7. PubMed ID: 10200293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge.
    Belyakov IM; Derby MA; Ahlers JD; Kelsall BL; Earl P; Moss B; Strober W; Berzofsky JA
    Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1709-14. PubMed ID: 9465081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of novel type I interferon epsilon in viral infection and mucosal immunity.
    Xi Y; Day SL; Jackson RJ; Ranasinghe C
    Mucosal Immunol; 2012 Nov; 5(6):610-22. PubMed ID: 22617838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with a Shigella DNA vaccine vector induces antigen-specific CD8(+) T cells and antiviral protective immunity.
    Shata MT; Hone DM
    J Virol; 2001 Oct; 75(20):9665-70. PubMed ID: 11559798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization strategies to augment oral vaccination with DNA and viral vectors expressing HIV envelope glycoprotein.
    Wierzbicki A; Kiszka I; Kaneko H; Kmieciak D; Wasik TJ; Gzyl J; Kaneko Y; Kozbor D
    Vaccine; 2002 Jan; 20(9-10):1295-307. PubMed ID: 11818148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional equivalency of B7-1 and B7-2 for costimulating plasmid DNA vaccine-elicited CTL responses.
    Santra S; Barouch DH; Jackson SS; Kuroda MJ; Schmitz JE; Lifton MA; Sharpe AH; Letvin NL
    J Immunol; 2000 Dec; 165(12):6791-5. PubMed ID: 11120800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-HIV env immunities elicited by nucleic acid vaccines.
    Shiver JW; Davies ME; Yasutomi Y; Perry HC; Freed DC; Letvin NL; Liu MA
    Vaccine; 1997 Jun; 15(8):884-7. PubMed ID: 9234539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen.
    Allen TM; Vogel TU; Fuller DH; Mothé BR; Steffen S; Boyson JE; Shipley T; Fuller J; Hanke T; Sette A; Altman JD; Moss B; McMichael AJ; Watkins DI
    J Immunol; 2000 May; 164(9):4968-78. PubMed ID: 10779808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein.
    Belyakov IM; Wyatt LS; Ahlers JD; Earl P; Pendleton CD; Kelsall BL; Strober W; Moss B; Berzofsky JA
    J Virol; 1998 Oct; 72(10):8264-72. PubMed ID: 9733870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay of cytokines and adjuvants in the regulation of mucosal and systemic HIV-specific CTL.
    Belyakov IM; Ahlers JD; Clements JD; Strober W; Berzofsky JA
    J Immunol; 2000 Dec; 165(11):6454-62. PubMed ID: 11086085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction, biological activity, and immunogenicity of synthetic envelope DNA vaccines based on a primary, CCR5-tropic, early HIV type 1 isolate (BX08) with human codons.
    Corbet S; Vinner L; Hougaard DM; Bryder K; Nielsen HV; Nielsen C; Fomsgaard A
    AIDS Res Hum Retroviruses; 2000 Dec; 16(18):1997-2008. PubMed ID: 11153083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sites.
    Horner AA; Datta SK; Takabayashi K; Belyakov IM; Hayashi T; Cinman N; Nguyen MD; Van Uden JH; Berzofsky JA; Richman DD; Raz E
    J Immunol; 2001 Aug; 167(3):1584-91. PubMed ID: 11466380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene combination raises broad human immunodeficiency virus-specific cytotoxicity.
    Calarota SA; Kjerrström A; Islam KB; Wahren B
    Hum Gene Ther; 2001 Sep; 12(13):1623-37. PubMed ID: 11535166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses.
    Sakaue G; Hiroi T; Nakagawa Y; Someya K; Iwatani K; Sawa Y; Takahashi H; Honda M; Kunisawa J; Kiyono H
    J Immunol; 2003 Jan; 170(1):495-502. PubMed ID: 12496436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization.
    Tobery TW; Siliciano RF
    J Exp Med; 1997 Mar; 185(5):909-20. PubMed ID: 9120397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of DNA-mediated immunization procedures directed against surface glycoproteins of human immunodeficiency virus type-1 and hepatitis B virus.
    Fomsgaard A; Nielsen HV; Nielsen C; Johansson K; Machuca R; Bruun L; Hansen J; Buus S
    APMIS; 1998 Jun; 106(6):636-46. PubMed ID: 9725796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A vaccinia-gp160-based vaccine but not a gp160 protein vaccine elicits anti-gp160 cytotoxic T lymphocytes in some HIV-1 seronegative vaccinees.
    Perales MA; Schwartz DH; Fabry JA; Lieberman J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):27-35. PubMed ID: 7648281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine.
    Fuller DH; Haynes JR
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1433-41. PubMed ID: 7888198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.